Question 1

Does Balyasny Asset Management own IOVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Balyasny Asset Management holds 373,284 shares of IOVA (Iovance Biotherapeutics), worth $1.6M.

Question 2

How many shares of IOVA does Balyasny Asset Management own?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management holds 373,284 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is Balyasny Asset Management's IOVA position worth?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management's IOVA position is worth $1.6M.

Question 4

Is Balyasny Asset Management buying or selling IOVA?

Accepted Answer

In Q2 2026, Balyasny Asset Management increased its IOVA position by 124,520 shares (+50.1%).

Question 5

When did Balyasny Asset Management first buy IOVA?

Accepted Answer

Balyasny Asset Management already held IOVA in its Q4 2018 13F, the earliest on record, and has listed it in 26 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	373,284	+50.1%	$1.6M	0.0%	$4.16	35
2026-Q1	Increased	248,764	+265.6%	$873,162	0.0%	$3.51	40
2025-Q4	Decreased	68,038	-24.9%	$185,744	0.0%	$2.73	0
2025-Q3	Decreased	90,624	-94.0%	$196,654	0.0%	$2.17	0
2025-Q2	Increased	1.5M	+618.2%	$2.6M	0.0%	$1.72	42
2025-Q1	Decreased	209,941	-92.5%	$699,104	0.0%	$3.33	0
2024-Q4	Decreased	2.8M	-37.0%	$20.9M	0.0%	$7.40	0
2024-Q3	Decreased	4.5M	-1.5%	$42M	0.1%	$9.39	0